BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
4.340
+0.080 (1.88%)
At close: Dec 10, 2025, 4:00 PM EST
4.330
-0.010 (-0.23%)
After-hours: Dec 10, 2025, 7:08 PM EST
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $7.8 million as of December 10, 2025. Its market cap has increased by 49.02% in one year.
Market Cap
7.80M
Enterprise Value
5.14M
1-Year Change
49.02%
Ranking
Category
Stock Price
$4.34
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $7.80M, a decrease of -81.49%. That is a compound annual growth rate of -27.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 7.80M | 55.14% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 182.29B |
| BHP Group | 149.65B |
| Rio Tinto Group | 126.11B |
| Southern Copper | 115.00B |
| Newmont | 102.51B |
| Agnico Eagle Mines | 83.48B |
| CRH plc | 82.91B |
| The Sherwin-Williams Company | 79.15B |